Western Botanicals Sold to Riverside in BGL's Fourth VMS Deal
Event summary
- Brown Gibbons Lang & Company (BGL) facilitated the sale of Western Botanicals to The Riverside Company on February 18, 2026.
- This marks BGL's third transaction in the CDMO subsector and fourth within the broader VMS industry.
- Western Botanicals operates three FDA-registered, cGMP- and NSF-compliant facilities totaling over 140,000 square feet.
- The acquisition aligns with Riverside's health, longevity, and flavor investment thesis.
The big picture
The sale of Western Botanicals to Riverside underscores the growing M&A activity in the VMS and CDMO sectors, driven by long-term demographic and wellness trends. BGL's repeated transactions in this space highlight the strategic importance of contract manufacturing in the health and wellness industry. The deal reflects Riverside's focus on businesses benefiting from innovation and demographic shifts, positioning Western Botanicals for further expansion.
What we're watching
- Growth Strategy
- How Riverside will leverage Western Botanicals' resources to expand into underpenetrated product categories and new geographic markets.
- Industry Tailwinds
- Whether the evolving consumer health consciousness and preventative healthcare trends will sustain the VMS industry's growth.
- Operational Integration
- The pace at which Western Botanicals integrates Riverside's capital and strategic direction into its existing operations.
Related topics